Maze Therapeutics Stock Still Climbing After March Tumble
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
15,537 articlesMaze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
A new Milken-Harris poll shows 80% of Americans want government-backed AI workforce programs now, with 68% feeling th...
Lucid represents a high-risk, high-reward bet in the EV space. Before you consider investing, these three practical f...
Trump’s idea to take government stakes in U.S. firms is back in the national conversation, with investors weighing po...
Sponsors are pulling back after reports of a strip club atmosphere at a major crypto conference after-party in Miami....
Ostium announced a strategic partnership with Nasdaq to power its onchain perpetuals with real-time Nasdaq data, aimi...
The Vatican has established a dedicated AI commission as Pope Leo XIV prepares a papal encyclical on AI ethics with A...
A surge in XRP trading on key exchanges has investors buzzing. This sign that better could point to shifting sentimen...
The Palmetto State signs a sweeping digital-asset measure banning CBDC use by state agencies and doubling down on cry...